The introduction of nicotinamide for a nicotine alternative in e-cigarette and smokeless items signifies a substantial regulatory obstacle to the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is thought to act as a sedative at large dosages6. The claims created by Nicotine